# Sofie Co dba Sofie – FDA Inspection, Jul 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/9a2591b4-4fc2-4877-b648-1b3870f57398
Source feed: FDA_Inspections

> FDA inspection 1276824 of Sofie Co dba Sofie, July 25, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 212. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276824
- Company Name: Sofie Co dba Sofie
- Inspection Date: 2025-07-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1073264 - 2018-12-03](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/08096f94-1e16-4a8c-8638-9bc39013d79d)
- FDA Inspection 924228 - 2015-01-23
- FDA Inspection 817083 - 2013-02-01
- FDA Inspection 675342 - 2010-08-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/4c07e010-a465-4c86-b712-d1ee6e051f30

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa